Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.65, No.3, p.469-476, 2018 |
||
Title: FOXA1 and CK7 expression in esophageal squamous cell carcinoma and its prognostic significance | ||
Author: Y. XU, W. WANG, L. LI, J. LIU, X. WU, J. YU, H. WANG, W. CUI, R. ZHANG | ||
Abstract: Esophageal Squamous Cell Carcinoma (ESCC) is one of the most common malignant tumors in human. Some ESCC cells express adenocarcinoma cell markers, such as Cytokeratin 7 (CK7), but the clinical significance of these cells in ESCC is unknown. Immunohistochemical analysis of CK7 and Fork head box protein A1 (FOXA1, an upstream regulator of CK7) was performed on 610 ESCC specimens using tissue microarray. In total, positive staining of CK7 was 59/594 (10%). CK7 expression was correlated with ESCC differentiation (p=0.006). The expression of CK7 is associated with poor overall survival (OS) of ESCC patients (p=0.0498). FOXA1 positive staining was 180/586 (31%). FOXA1 expression correlates with differentiation (p can be used as potential targets for ESCC therapy. |
||
Keywords: FOXA1, CK7, esophageal squamous cell carcinoma, prognosis | ||
Published online: 16-May-2018 | ||
Year: 2018, Volume: 65, Issue: 3 | Page From: 469, Page To: 476 | |
doi:10.4149/neo_2018_170529N384 |
||
|
download file |
|